﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd"[]>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Science and Education Publishing</PublisherName>
      <JournalTitle>American Journal of Pharmacological Sciences</JournalTitle>
      <Volume>1</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>-1</Month>
        <Day>29</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>Screening of the Anticonvulsant Activity of Some Isatin Derivatives in Experimental Seizure Models and Its Effect on Brain GABA Levels in Mice</ArticleTitle>
    <FirstPage>42</FirstPage>
    <LastPage>46</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Venkateshwarlu</FirstName>
        <LastName>Eggadi</LastName>
      </Author>
      <Author>
        <FirstName>Umasankar</FirstName>
        <LastName>Kulandaivelu</LastName>
      </Author>
      <Author>
        <FirstName>Sharvanabhava B</FirstName>
        <LastName>S</LastName>
      </Author>
      <Author>
        <FirstName>Venkateshwar Rao</FirstName>
        <LastName>Jupally</LastName>
        <Affiliation>TallaPadmavathi College of Pharmacy, Orus, Warangal, India</Affiliation>
      </Author>
    </AuthorList>
    <ArticleIdList>
      <ArticleId IdType="pii">AJPS2013133</ArticleId>
      <ArticleId IdType="doi">10.12691/ajps-1-3-3</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2012</Year>
        <Month>12</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="revised">
        <Year>2013</Year>
        <Month>-1</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2013</Year>
        <Month>-1</Month>
        <Day>29</Day>
      </PubDate>
    </History>
    <Abstract>The modern therapeutic approaches of antiepileptic agents against epileptic patients are showing many side effects, dose related effects and chronic toxicity. The aim of our present work is to evaluate anticonvulsant activity of isatin derivatives (<b>Ia-Ij</b>) to reduce the side-effects and increase the percentage protection from various stages of convulsions. No animals showed toxic effects even up to 2000mg/kg. It is evident that <b>Ib, Ie, Ih, Ii </b>and<b> Ij </b>showed anticonvulsant effect at the dose levels of 10 and 100mg/kg in MES test and except <b>Ij</b> all other derivatives exhibited antiepileptic effect at 10 and 100mg/kg in PTZ induced convulsions test. The isatin derivatives<b></b>(<b>Ib, Ie, Ih </b>and<b> Ii</b>) which proved antiepileptic effect in both MES and PTZ induced convulsion models are selected and GABA levels in brain were estimated. They showed significant increase of GABA levels in brain.</Abstract>
  </Article>
</ArticleSet>